Stay updated on SAGE-718 Effects in AD: Mild Cognitive Impairment Clinical Trial
Sign up to get notified when there's something new on the SAGE-718 Effects in AD: Mild Cognitive Impairment Clinical Trial page.

Latest updates to the SAGE-718 Effects in AD: Mild Cognitive Impairment Clinical Trial page
- Check6 days agoChange DetectedThe page footer now lists Revision: v3.3.2, replacing Revision: v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check13 days agoChange DetectedFooter shows Revision: v3.3.1, replacing Revision: v3.2.0. This is a minor site version update and does not modify study details or navigation.SummaryDifference0.0%

- Check20 days agoChange DetectedRemoved a site-wide notice about a lapse in government funding and NIH/CC operating status that previously appeared on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check34 days agoChange DetectedNo significant changes detected in the Study Details page; essential information remains unchanged.SummaryDifference0.4%

- Check63 days agoChange DetectedUpdated the page to v3.2.0 with a prominent notice about potential data/tansaction delays due to funding gaps and where to check operating status; previous v3.1.0 reference removed.SummaryDifference3%

- Check70 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.SummaryDifference0.1%

Stay in the know with updates to SAGE-718 Effects in AD: Mild Cognitive Impairment Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SAGE-718 Effects in AD: Mild Cognitive Impairment Clinical Trial page.